Clinical Trials Directory

Trials / Completed

CompletedNCT05809739

Effectiveness and Safety of STYLAGE® HYDRO in the Treatment of Face, Neckline Area and Neck

FLASH Study: Effectiveness and Safety of STYLAGE® HYDRO in the Treatment of Face, Neckline Area and Neck

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
85 (actual)
Sponsor
Laboratoires Vivacy · Industry
Sex
Female
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

FLASH Study is a Post-Market Follow-Up PCMF designed to evaluate the tolerance and efficacy of STYLAGE Hydro by using a satisfaction questionnaire.

Detailed description

This is a prospective, in open, single arm and multicentric study designed to evaluate the tolerance and efficacy of STYLAGE Hydro. Patients will be injected up to 2 mL of STYLAGE Hydro per area at each session. Three injection sessions 2 weeks apart are planned: one at visit 1 (D0), one at visit 2 (W2) and one at visit 3 (W4). Proportions of subjects who are satisfied on the face 6 weeks after treatment initiation will be assessed. For each question of the questionnaire, the subjects who are satisfied are defined as subjects who rated "Somewhat agree", "Agree" or "Totally agree". Global aesthetic improvement according to independent evaluator and subjects' satisfaction will also be done during other visits. Safety parameters will be evaluated during the study period.

Conditions

Interventions

TypeNameDescription
DEVICESTYLAGE Hydro3 sessions of injections (J0, J14 and J28)

Timeline

Start date
2023-02-28
Primary completion
2023-12-31
Completion
2024-02-01
First posted
2023-04-12
Last updated
2024-02-16

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05809739. Inclusion in this directory is not an endorsement.